|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
MAXCYTE, INC. (Name of Issuer) |
Equity (Title of Class of Securities) |
(CUSIP Number) |
Jasmine Purohit 2 Savoy Court, London, X0, WC2R 0EZ 02039088827 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
10/30/2026 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Liontrust Investment Partners LLP | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED KINGDOM
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
5,081,403.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
4.9 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IV |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Equity |
| (b) | Name of Issuer:
MAXCYTE, INC. |
| (c) | Address of Issuer's Principal Executive Offices:
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE,
MARYLAND
, 20850. |
| Item 2. | Identity and Background |
| (a) | Liontrust Investment Partners LLP |
| (b) | 2 Savoy Court, London, WC2R 0EZ, United Kingdom |
| (c) | Investment Firm
2 Savoy Court, London, WC2R 0EZ, United Kingdom |
| (d) | No |
| (e) | No |
| (f) | United Kingdom |
| Item 3. | Source and Amount of Funds or Other Consideration |
N/A | |
| Item 4. | Purpose of Transaction |
(a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | 5,081,403
4.9235%
|
| (b) | 5,081,403 |
| (c) | Trade Date BUY/SELL Trade Face Trade Price
06-Aug-2026 SELL 104321 1.10126602
01-Sep-2026 SELL 81203 1.23950150
02-Sep-2026 SELL 63958 1.25395358
03-Sep-2026 SELL 54839 1.24421552
08-Sep-2026 SELL 41034 1.26752510
09-Sep-2026 SELL 37115 1.23726948
10-Sep-2026 SELL 29095 1.19462212
11-Sep-2026 SELL 32615 1.17414454
14-Sep-2026 SELL 74036 1.14991057
07-Oct-2026 SELL 3111 1.04626808
14-Oct-2026 BUY 138139 1.26072563
14-Oct-2026 BUY 175694 1.26072563
14-Oct-2026 BUY 43113 1.26072563
30-Oct-2026 SELL 112919 1.56814936
|
| (d) | n/a |
| (e) | 10/30/2026 |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
n/a | |
| Item 7. | Material to be Filed as Exhibits. |
n/a |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|